Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research?
Open Access
- 6 April 2020
- journal article
- letter
- Published by Elsevier BV in Contemporary Clinical Trials
- Vol. 92, 105997
- https://doi.org/10.1016/j.cct.2020.105997
Abstract
No abstract availableKeywords
Funding Information
- Prostate Cancer Foundation
- Lazarex Cancer Foundation
This publication has 8 references indexed in Scilit:
- How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trialsContemporary Clinical Trials Communications, 2019
- Examining urban and rural differences in perceived timeliness of care among cancer patients: A SEER‐CAHPS studyCancer, 2018
- At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical TrialsThe Oncologist, 2018
- Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity ProgramThe Oncologist, 2016
- Recognizing the Financial Burden of Cancer Patients in Clinical TrialsThe Oncologist, 2015
- Reducing Clinical Trial Monitoring Resource Allocation and Costs Through Remote Access to Electronic Medical RecordsJournal of Oncology Practice, 2013
- Specific barriers to the conduct of randomized trialsClinical Trials, 2008
- Participation in Cancer Clinical TrialsJama-Journal Of The American Medical Association, 2004